Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure

Kidney International

Volumn 51, Issue 3, 1997, Pages 622-630

  Erslev, A J ^a   Besarab, A ^a  

^a Cardeza Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; CHRONIC KIDNEY FAILURE; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030964765     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.91     Document Type: Editorial

References (93)

1. R. Bright Cases and observations, illustrative of renal disease accompanied with the secretion of albuminous urine Guys Hosp Rep 1 1836 338 400
2. L.O. Jacobson L.F. Goldwasser W. Fried L. Plzak Role of the kidney in erythropoiesis Nature 179 1957 633 634
3. A.J. Erslev Renal biogenesis of erythropoietin Am J Med 58 1975 25 30
4. M.A. Esteban A. Garcia Ayala B. Aquilero Erythropoiesis and thrombopoiesis in the head kidney of the Sea Bass (Dicentrachus labrax L.). An ultrastructural study Arch Histol Cytol 52 1989 407 419
5. A.J. Erslev J. Caro A. Besarab Why the kidney Nephron 41 1985 213 216
6. H.J. Schurek U. Jost H. Bertram Baumgärtl Preglomerular cortical oxygen diffusion shunt: A prerequisite for effective erythropoietin regulation C.A. Baldamus P. Scigalla L. Wieczorek K.M. Koch Erythropoietin: From Molecular Structure to Clinical Application 76 1989 Karger Basel 57 66
7. A.J. Erslev Feedback circuits in the control of stem cell differentiation Am J Pathol 65 1971 629 639
8. E. Goldwasser The structure-function relationship of erythropoietin A.J. Erslev J.W. Adamson J.W. Eschbach C.G. Winearls Erythropoietin–Molecular, Cellular, and Clinical Biology 1991 The Johns Hopkins University Press Baltimore 41 52
9. A.J. Erslev J. Caro O. Miller R. Silver Plasma erythropoietin in health and disease Ann Clin Lab Sci 10 1980 250 257
10. J.C. Egrie J.K. Browne The molecular biology of erythropoietin A.J. Erslev J.W. Adamson J.W. Eschbach C.G. Winearls Erythropoietin–Molecular, Cellular, and Clinical Biology 1991 The Johns Hopkins University Press Baltimore 21 40
11. I. Beck S. Ramirez R. Weinmann J. Caro Enhancer element at the 3′ flanking region controls transcriptional response to hypoxia in the human erythropoietin gene J Biol Chem 266 1991 15563 15566
12. G.L. Semenza M.K. Nejfelt S.M. Chi S.E. Antonarakis Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene Proc Natl Acad Sci USA 88 1991 5680 5684
13. G.L. Semenza G.L. Wang A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation Mol Cell Biol 12 1992 5447 5454
14. G.L. Wang G.L. Semenza General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia Proc Natl Acad Sci USA 90 1993 4304 4308
15. S.T. Koury M.C. Bondurant M.J. Koury Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridization Blood 71 1988 524 527
16. S.T. Koury M.J. Koury M.C. Bondurant J. Caro S.E. Graber Quantitation of erythropoietin producing cells in kidneys of mice by in situ hybridization: Correlation with hematocrit, renal erythropoietin RNA, and serum erythropoietin concentration Blood 74 1989 645 651
17. A.J. Erslev J. Caro E. Kansu R. Silver Renal and extrarenal erythropoietin production in anaemic rats Br J Haemat 45 1980 65 72
18. E. Goldwasser L.O. Jacobson W. Fried L.F. Plzak Studies on erythropoiesis, V: The effect of cobalt on the production of erythropoietin Blood 13 1958 55 60
19. N.T. Shahidi Androgens and erythropoiesis N Engl J Med 289 1973 72 80
20. N. Dainiak Control of hematopoietic cell growth by somatomedins Exp Hematol 21 1993 1405 1407
21. W.C. Faquin T.J. Schneider M.A. Goldberg Effect of inflammatory cytokines on hypoxia-induced erythropoietin production Blood 79 1992 1987 1994
22. W. Jelkmann H. Pagel M. Wolff J. Fandrey Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys Life Sci 50 1991 301 308
23. D.S. Krause M.J. Fackler C.I. Civin W.S. May CD34: Structure, biology, and clinical utility Blood 87 1996 1 13
24. M. Ogawa Differentiation and proliferation of hematopoietic stem cells Blood 81 1993 2844 2853
25. J.R. Stephenson A.A. Axelrod D.L. McLeod M.M. Shreve Induction of hemoglobin-synthesizing cells by erythropoietin in vitro Proc Natl Acad Sci USA 65 1971 1542 1546
26. A.D. D'Andrea H.F. Lodish G.G. Wong Expression cloning of the murine erythropoietin receptor Cell 57 1989 277 285
27. U. Klingmüller U. Lorenz L.C. Cantley B.G. Neel H.F. Lodish Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals Cell 80 1995 729 738
28. M.J. Koury M.C. Bondurant Erythropoietin retards DNA break-down and prevents programmed death in erythroid progenitor cells Science 248 1990 378 381
29. J.W. Adamson B. Torok-Storb N. Lin Analysis of erythropoiesis by erythroid colony formation in culture Blood Cells 4 1978 89 103
30. J. Caro A.J. Erslev Anemia of chronic renal failure E. Beutler M.A. Lichtman B.S. Coller T.J. Kipps Williams Hematology 5th ed 1995 McGraw-Hill New York 456 462
31. A. Levin J. Singer C.R. Thompson H. Ross M. Lewis Prevalent left ventricular hypertrophy in the pre-dialysis population identifying opportunities for intervention Am J Kid Dis 27 1996 347 354
32. A.J. Erslev A. Besarab The rate and control of baseline red cell production in hematologically stable patients with uremia J Lab Clin Med 126 1995 283 286
33. W. Jelkmann Renal erythropoietin: Properties and production Rev Physiol Bioch Pharm 104 1986 139 215
34. A. Besarab J. Caro B.E. Jarrell G. Francos A.J. Erslev Dynamics of erythropoiesis following renal transplantation Kidney Int 32 1987 526 536
35. R. Ross J.B. McCrea A. Besarab Erythropoietin response to blood loss in hemodialysis patients is blunted but preserved ASAIO J 40 1994 M880 M885
36. H.W. Radtke U. Frei P.M. Erbes W. Schoeppe K.M. Koch Improving anemia by hemodialysis. Effect on serum erythropoietin Kidney Int 17 1980 382 387
37. H.W. Radtke A.B. Rege B. Lamarche D. Bartos F. Bartos R.A. Cambell J.W. Fisher Identification of spermine as an inhibitor of erythropoiesis in patients with chronic renal failure J Clin Invest 67 1981 1623 1629
38. S.G. Massry Is parathyroid hormone an uremic toxin Nephron 19 1977 125 130
39. J. Caro A.J. Erslev Uremic inhibitors of erythropoiesis Semin Nephrol 5 1985 128 132
40. J.W. Eschbach N.R. Haley J.C. Egrie J.W. Adamson A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects Kidney Int 42 1992 407 416
41. Erslev AJ, Besarab A, Ballas SK: The rate of red cell production in renal and sickle cell anemia, in Second International Symposium on the Erythron and Iron Metabolism Pathology , Ryazan, Russia (in press)
42. U. Essers Use of erythropoietin in the treatment of patients with anemia of renal insufficiency American Society of Hematology 1973 Illinois Chicago December 1–4
43. C.G. Winearls D.O. Oliver M.J. Pippard C. Reid M.R. Downing P.M. Coles Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis Lancet 2 1986 1175 1178
44. J.W. Eschbach J.C. Egrie M.R. Downing J.K. Browne J.W. Adamson Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of combined phase I & II clinical trials N Engl J Med 316 1987 73 78
45. C.G. Winearls Historical review of the use of recombinant human erythropoietin in chronic renal failure Nephrol Dial Transplant 10 Suppl 2 1995 3 9
46. J.W. Eschbach M.H. Abdulhadi J.K. Browne B.G. Delano M.R. Downing J.C. Egrie R.W. Evans E.A. Friedman S.E. Graber N.R. Haley S. Korbet S.B. Krantz P.A. Lundin A.R. Nissenson D.A. Ogden E.P. Poganini B. Rader E.A. Rutsky J. Stivelman W.J. Stone P. Teschan J.C. Van Stone D.B. Van Wyck K. Zuckerman J.W. Adamson Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial Ann Int Med 111 1989 992 1000
47. R.W. Evans Recombinant human erythropoietin and the quality of life of end-stage renal disease patients: A comparative analysis Am J Kidney Dis 18 Suppl 1 1991 S62 S70
48. Canadian Erythropoietin Study Group Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis Br Med J 300 1990 573 578
49. P. Barany E. Petterson J.K. Konarski-Svensson Long-term effects on quality of life in haemodialysis patients by correction of anaemia with erythropoietin Nephrol Dial Transplant 8 1993 426 432
50. M. Metra G. Cannella G. La Canna T. Guaini M. Sandrini M. Gaggiotti E. Movilli I. Dei Cas Improvement in exercise capacity after correction of anemia in patients with end-stage renal failure Am J Cardiol 68 1991 1060 1066
51. S.K. Fellner R.M. Lang A. Neumann C. Korcarz K.M. Borow Cardiovascular consequences of the correction of the anemia of renal failure with erythropoietin Kidney Int 44 1993 1309 1315
52. A. Davenport The effect of treatment with recombinant human erythropoietin on skeletal muscle function in patients with end-stage renal failure treated with regular hemodialysis Am J Kidney Dis 22 1993 685 690
53. L.A. Hebert D.J. Birmingham J.J. Dillon F.G. Cosio X.P. Shen Erythropoietin therapy in humans increases erythrocyte expression of complement receptor 1 (CD35) J Am Soc Nephrol 4 1994 1786 1791
54. U. Gaffer Y. Kalechman J.B. Orlin J. Levi B. Sredni Anemia of uremia is associated with reduced in vitro cytokine secretion: Immunopotentiating activity of red blood cells Kidney Int 45 1994 224 231
55. D.H. Berman E.A. Friedman Partial absorption of hard exudates in patients with diabetic end-stage renal disease and severe anemia after treatment with erythropoietin Retina 14 1994 1 5
56. J.W. Eschbach M.R. Kelly N.R. Haley R.I. Abels J.W. Adamson Treatment of the anemia of progressive renal failure with recombinant human erythropoietin N Engl J Med 321 1989 158 163
57. P.A. Abraham J.A. Opsahl K.M. Rachael R. Asinger C.E. Halstenson Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients Am J Nephrol 10 1990 128 136
58. U.S. Recombinant Human Erythropoietin Predialysis Group Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients Am J Kidney Dis 14 1991 50 59
59. M. Navarro A. Alonso J.M. Avilla L. Espinosa Anemia of chronic renal failure: Treatment with erythropoietin Child Nephrol Urol 11 1991 146 151
60. Austrian Multicenter Study Group of r-HuEPO in Predialysis Patients Effectiveness and safety of recombinant human erythropoietin in predialysis patients Nephron 61 1992 399 403
61. P. Kulzer R.M. Schaefer R. Krahn L. Schaefer A. Heidland Effectiveness and safety of recombinant human erythropoietin in the treatment of anemia of chronic renal failure in non-dialysis patients Int J Art Organs 17 1994 192 202
62. A. Mitwalli H. Abuaisha J. al Wakeel S. al Mohaya A.A. Alam H. Gamal H. Fayed Effectiveness of low-dose erythropoietin in predialysis chronic renal failure Nephrol Dial Transplant 8 1993 1085 1088
63. G. Maschio Erythropoietin and systemic hypertension Nephrol Dial Transplant 10 Suppl 2 1995 4 79
64. L.A.M. Frencken J.F.M. Wetzels H.E. Sluitter R.A.P. Koene Evidence for renal vasodilatation in pre-dialysis patients during correction of anemia by erythropoietin Kidney Int 41 1992 384 387
65. H.M. Steffen R. Brunner R. Müller S. Degenhardt M. Pollok R. Lang C.A. Baldamus Peripheral hemodynamics, blood viscosity, and the renin-angiotensin system in hemodialysis patients under therapy with recombinant human erythropoietin Contrib Nephrol 6 1989 292 298
66. E. Anastassiades D. Howarth J. Howarth D. Shanks H. Waters K. Hyde J.L. Yin C. Geary R. Gokal Influence of blood volume on the blood pressure of predialysis and peritoneal dialysis patients treated with erythropoietin Nephrol Dial Transplant 8 1993 621 625
67. G. Maschio Erythropoietin and systemic hypertension Nephrol Dial Transplant 10 Suppl 2 1995 621 625
68. G. Hon N.D. Vaziri C.J. Kaupke A. Tehranzadeh C. Barton Lack of fast-acting effect on arterial blood pressure and endothelin level Artif Organs 19 1995 188 191
69. C.J. Kaupke S. Kim N.D. Vaziri Effect of erythrocyte mass on arterial blood pressure in dialysis patients receiving erythropoietin therapy J Am Soc Nephrol 4 1994 1874 1878
70. V.S. Lim P.T. Kirchner J. Fangman J. Richmond R.L. De Gowen The safety and efficacy of maintenance therapy of recombinant human erythropoietin treatment in patients with renal insufficiency Am J Kidney Dis 14 1989 496 506
71. N. Goldberg A.P. Lundin B. Delano E.A. Friedman R.A. Stein Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietin Am Heart J 124 1992 424 427
72. V. Wizemann N. Kaufman W. Kramer Effect of erythropoietin on ischemic tolerance in anemic hemodialysis patients with confirmed coronary artery disease Nephron 62 1992 161 165
73. L.P. McMahon J.A. Johns A. McKenzie M. Austin R. Fowler J.K.L. Dawborn Haemodynamic changes and physical performance at comparative levels of haemoglobin after long-term treatment with recombinant erythropoietin Nephrol Dial Transplant 7 1992 1199 1206
74. S.R. Acchiardo B.P. Quinn L.W. Moore L.B. Burk D.E. Miles Evaluation of hemodialysis patients treated with erythropoietin Am J Kidney Dis 17 1991 290 294
75. T. Baur M. Lundberg Secondary effects of erythropoietin treatment on metabolism and dialysis efficiency in stable hemodialysis patients Clin Nephrol 34 1990 230 235
76. N. Veys R. Vanholder K. De Guyper S. Ringoir Influence of erythropoietin on dialyzer re-use, heparin needs, and urea kinetics in maintenance hemodialysis patients Am J Kidney Dis 23 1994 52 59
77. A. Ksiazek E. Baranowska-Daca Hematocrit influence on peritoneal dialysis effectiveness during recombinant human erythropoietin treatment in patients with chronic renal failure Petit Dial Int 13 Suppl 2 1993 S550 S552
78. D.N. Churchill N. Muirhead M. Goldstein G. Posen W. Fay M.L. Beecroft J. Gorman D.W. Taylor Probability of thrombosis of vascular access among hemodialysis patients treated with recombinant human erythropoietin J Am Soc Nephrol 4 1994 1809 1813
79. B.A. Standage E.S. Schuman D. Ackerman G.F. Gross J.W. Ragsdale Does the use of erythropoietin in hemodialysis increase dialysis graft thrombosis rates Am J Surgery 165 1993 650 654
80. N. Muirhead J. Bargman E. Burgess K.K. Jindal A. Levin L. Nolin P. Parfrey Evidence-based recommendation for the clinical use of recombinant human erythropoietin Am J Kidney Dis 26 Suppl 1 1995 S1 S24
81. N.R. Powe R.I. Griffiths E.B. Bass Cost-implications to Medicare of recombinant erythropoietin therapy for the anemia of end-stage renal disease J Am Soc Nephrol 3 1993 1660 1671
82. N.R. Powe R.I. Griffiths A.J. Watson G.F. Anderson G. de Lissovoy J.W. Greer R.J. Herbert R.A. Milam P.K. Whelton Effect of recombinant erythropoietin on hospital admissions, readmissions, length of stay, and costs of dialysis patients Am Soc Nephrol 4 1994 1455 1465
83. D.E. Uehlenger F.A. Gotch C.B. Steiner A pharmacodynamic model of erythropoietin therapy for uremic anemia Clin Pharmacol Ther 51 1992 76 89
84. A. Besarab J.B. McCrea P.H. Vlasses F. Medina J. Caro E. Morris Clinical pharmacology and economics of recombinant human erythropoietin in end-stage renal disease: The case for subcutaneous administration J Am Soc Nephrol 2 1992 1405 1416
85. N.I. Ashai E.P. Paganni J.M. Wilson Intravenous versus subcutaneous dosing of epoetin: A review of the literature Am J Kidney Dis 22 Suppl 1 1993 23 31
86. I.C. Macdougall B. Tucker J. Thompson L.R.I. Baker A.E.G. Raine A randomized controlled study of iron supplementation in patients treated with erythropoietin J Am Soc Nephrol 4 1993 428 (abstract)
87. S. Fishbane G.L. Frei J. Maesaka Reduction in recombinant human erythropoietin doses by the use of chronic iron supplementation Am J Kidney Dis 26 1995 41 46
88. S.B. Krantz Erythropoietin and the anemia of chronic disease Nephrol Dial Transplant 10 Suppl 2 1995 10 17
89. I.C. Macdougall How to get the best out of r-HuEPO Nephrol Dial Transplant 10 Suppl 2 1995 85 91
90. O. Ifudu J. Feldman E.A. Friedman The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease N Engl J Med 334 1996 420 425
91. T.B. Druecke Modulating factors in the hematopoietic response to erythropoietin Am J Kidney Dis 18 Suppl 1 1991 87 92
92. D.S. Rao M.-S. Shih R. Mohini Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia N Engl J Med 328 1993 171 175
93. N. Casadevall E. Dupuy P. Molho-Sabatier G. Tobelem B. Varet P. Mayeux Brief Report: Autoantibodies against erythropoietin in a patient with pure red-cell aplasia N Engl J Med 334 1996 630 633